Chemotherapy regimens in rare solid tumors / Alessandro Comandone.

Includes bibliographical references (pages 124-143).

Preface -- 1. Rare tumors of the thorax -- Mesothelioma -- Mesothelioma: Cisplatin + Pemetrexed -- Mesothelioma: Carboplatin + Pemetrexed -- Mesothelioma: Cisplatin + Gemcitabine -- Mesothelioma: Cisplatin + Doxorubicin -- Mesothelioma: Pemetrexed -- Mesothelioma: Pemetrexed + Gemcitabine -- Mesothelioma: Gemcitabine + Cisplatin -- Thymoma -- Thymoma: PAC -- Thymoma: PACE -- Thymoma: ADOC -- Thymoma: PE (EORTC) -- 2. Endocrine glands tumors -- Anaplastic thyroid carcinoma -- Anaplastic thyroid carcinoma: Doxorubicin + Cisplatin -- Anaplastic thyroid carcinoma: Doxorubicin -- Anaplastic thyroid carcinoma: Paclitaxel + GemcitabineMedullary thyroid carcinoma -- Medullary thyroid carcinoma: CVD -- Medullary thyroid carcinoma: Sz/M -- Carcinoma of parathyroid -- Parathyroid carcinoma: CFuD -- Parathyroid carcinoma: Dacarbazine -- Adrenocortical carcinoma -- Adrenocortical carcinoma: Mitotane -- Adrenocortical carcinoma: EDP/M -- Adrenocortical carcinoma: EP + Mitotane -- Adrenocortical carcinoma: Sz/M -- Feocromocitoma -- Feocromocitoma: CVD -- 3. Neuroendocrine tumors -- Gastroenteropancreatic neuroendocrine tumors (GEP) -- GEP: Streptozotocin + Doxorubicin -- GEP: Streptozotocin + 5-Fluorouracil -- GEP: FDEGEP: IFN -- GEP: Octreotide LAR -- GEP: Lanreotide -- GEP: DTIC -- Poorly-differentiated neuroendocrine tumor of different sites -- Poorly-differentiated neuroendocrine tumor: PE -- Poorly-differentiated neuroendocrine tumor: CAV -- Poorly-differentiated neuroendocrine tumor: Topotecan -- Poorly-differentiated neuroendocrine tumor: 5-Fluorouracil + Streptozotocin -- Poorly-differentiated neuroendocrine tumor: EC -- Poorly-differentiated neuroendocrine tumor: Etoposide orally -- Poorly-differentiated neuroendocrine tumor: PEC -- 4. Rare gynecological tumors -- Vulvar cancers -- Vulvar cancer: Radiotherapy + Cisplatin + 5-FluorouracilVulvar cancer: FUMIR (5-Fluorouracil + Mitomycin C + Radiotherapy) -- Vulvar cancer: Cisplatin + Bleomycin -- Vulvar cancer: Cisplatin + 5-Fluorouracil -- Vulvar cancer: Cisplatin + Vinorelbine -- Uterine sarcomas -- Uterine sarcomas (Leiomyosarcoma): HD-IFO -- Uterine sarcomas (Leiomyosarcoma): Dacarbazine -- Uterine sarcomas (Leiomyosarcoma): Dacarbazine -- Uterine sarcomas (Leiomyosarcoma): Doxorubicin -- Uterine sarcomas (Leiomyosarcoma): Doxorubicin + Ifosfamide -- Uterine sarcomas (Leiomyosarcoma): MAID -- Uterine sarcomas (Leiomyosarcoma): Trabectedin -- Uterine sarcomas (Leiomyosarcoma): Gemcitabine + DocetaxelCarcinosarcoma (mixed müllerian tumor): ITP -- Carcinosarcoma (mixed müllerian tumor): TAP -- Vaginal carcinoma -- Vaginal carcinoma: Cisplatin + Vinorelbine -- Vaginal carcinoma: Cisplatin + Bleomycin -- Vaginal carcinoma: BIP -- Vaginal carcinoma: BOMP -- Vaginal carcinoma: Cisplatin + 5-Fluorouracil -- Vaginal carcinoma: Cisplatin + Paclitaxel -- Vaginal carcinoma: Carboplatin + Paclitaxel -- 5. Rare tumors of male genital tract -- Testicular tumors and disgerminomas -- Testicular tumors and disgerminomas: BEP -- Testicular tumors: PVB -- 6. Sarcomas and GIST -- 7. Head and neck rare tumors -- 8. Gastrointestinal rare tumors -- 9. Raren tumors of the skin -- 10. Rare tumors of urniary tract -- References.

Testicular tumors: VeIP (rescue regimen).

Rare tumors are an increasing problem in oncology. Aim of this book is to offer a help in spreading the knowledge of low-incidence tumors in oncology. Each chapter provides brief information about the epidemiology of and clinical aspects for every RT; and, following each chemotherapy schedule, we report a short description of the hematologic toxicities related to the treatment.

Print version record.

eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide